Nike (NYSE:NKE | NKE Price Prediction) currently trades at $42.96, well below Wall Street’s average analyst price target of $51.12. That leaves a gap of roughly 19% between current levels and where the sell side sees fair value.
Nike has long served as a barometer for global consumer discretionary sentiment. A new CEO, a mid-turnaround portfolio, and one loud outlier from Morningstar have put the stock back on investor watch lists.
Morningstar’s discounted cash flow model pegs fair value at $94, implying the stock could roughly double if the firm’s long-term assumptions play out.
A Punishing 2026 Has Pushed Nike Near Multi-Year Lows
Nike has shed 31.51% year to date and 40.36% over the past 12 months. The stock printed a 52-week low of $40.00 and now sits below both its 50-day and 200-day moving averages.
The damage is operational. Greater China revenue fell 12% reported and 17% currency-neutral, Converse slid 32%, and Nike Direct dropped 7% as management rebalances toward wholesale. The Q1 FY27 EPS beat of $0.72 versus $0.13 was inflated by a $986 million one-time IEEPA tariff recovery, which added roughly $0.52 to EPS. Strip that out, and revenue still slipped 1.1% year over year.
Morningstar Sees Value Where the Market Sees Trouble
Morningstar’s $94 fair value implies upside of roughly 119% from current levels. The firm maintains a Wide Economic Moat rating on Nike based on global brand intangibles and pricing power, arguing that direct-to-consumer missteps and slowing lifestyle trends have not eroded the underlying franchise.
The DCF builds in a recovery trajectory to mid-single-digit sales growth and mid-teens operating margins over a three-year horizon as sport-led innovation rolls out and inventory discounting normalizes. Analyst Swartz frames the current $43 to $44 trading zone as heavily overdiscounting cyclical problems.
Sell-side consensus is far more cautious. The 38-analyst panel breaks down as 1 Strong Buy, 11 Buy, 24 Hold, 1 Sell, and 1 Strong Sell, a Hold-heavy stance reflecting skepticism on the pace of the “Win Now” turnaround. CEO Elliott Hill has called it the “middle innings of our comeback,” and recently bought roughly $1 million of stock on the open market. Nike has beaten EPS estimates for seven consecutive quarters, though recent beats have leaned heavily on cost management and one-time items rather than top-line strength.
How Athletic Footwear Peers Stack Up Against Nike
Nike fell alone. Across the athletic and premium footwear space, the drawdowns look nothing alike.
On Holding (NYSE:ONON) trades at $37.24, off 19.88% year to date, against a consensus target of $51.99 for implied upside near 40%. The 26 analysts skew clearly bullish, with 5 Strong Buys and 17 Buys versus only three Holds.
Deckers Outdoor (NYSE:DECK) is nearly flat on the year at $103.31, with a target of $127.81 and roughly 24% implied upside. The 26-analyst panel leans constructive with 11 Buy-equivalents against 13 Holds.
Lululemon Athletica (NASDAQ:LULU) sits at $116.63, down 43.88% year to date. Its $127.92 target implies just 10% upside, and the panel is overwhelmingly Hold, with 30 of 33 analysts parked on the sideline.
Nike sits between these extremes. Consensus upside is more modest than ONON’s, but Morningstar’s outlier target is by far the largest implied return in the group.
The Data Points That Define the Dislocation
Nike trades at $42.96, against a consensus target of $51.12 from 38 covering analysts and Morningstar’s $94. Trailing P/E is 21, forward P/E is 25, and the dividend yield sits at 3.75% after a 24th consecutive annual raise.
Nike has cratered 31.51% year to date, while the S&P 500 has advanced 9.73% over the same window. That is roughly 41 percentage points of relative underperformance for a Dow component.
Retail sentiment is fractured. Reddit chatter spiked bearish on a “Nike Shoes are a Dying Brand” thread in r/stocks before recovering to a bullish 76 sentiment score in mid-July.
Where I Land on Nike at $43
The bull path requires Elliott Hill’s “Sport Offense” framework to translate into North America product wins in the back half of fiscal 2027, Greater China to stop accelerating downward, and gross margin to hold above 44% ex-tariff noise. That is the specific path back toward the $51 consensus, with Morningstar’s $94 requiring several more years of mid-single-digit growth and mid-teens operating margins.
The bear path plays out if Converse keeps falling at a 30%-plus clip, if Nike Direct/Digital declines widen rather than narrow, and if China moves from bad quarter to broken franchise. Any of those turns the current setup into a classic value trap.
The CEO’s open-market purchase, the moat, and the multi-year Morningstar math tilt the risk/reward in favor of patient buyers, though the setup rewards discipline rather than momentum chasing. Patient buyers may prefer to build exposure gradually as the turnaround proves itself, quarter by quarter.
Contact [email protected] for any questions or corrections.
Top Gaining Stocks
Top Losing Stocks